Global Polymer Nanoparticles (PNP) Formulation Development Market Research Report 2024

Publication ID:

PB511243246

Publication Date:

November 4, 2024

Pages:

Publisher:

MRRPB5

Countries:

Global [1]

USD 2,900.00

Pharmaceutical Manufacturing [2]

Healthcare [3]

Pharma & Healthcare [4]

Description:

PNPs are an alternative to LNP formulations that include cationic lipids.Polymer nanoparticles are solid particles made out of polymers that range between 1 to 100 nm in size. For drug delivery, there are different types of biocompatible polymers used in the pharmaceutical industry to make NPs. The common polymers used for drug delivery include polylactic acid (PLA), polyglycolic acid (PGA), and lactic acid and glycolic acid copolymers (PLGA) because they are known to be biodegradable, biocompatible, non-toxic, and are FDA approved for biomedical applications.
The global Polymer Nanoparticles (PNP) Formulation Development market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of %during the forecast period 2024-2030.
North American market for Polymer Nanoparticles (PNP) Formulation Development is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Polymer Nanoparticles (PNP) Formulation Development is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Polymer Nanoparticles (PNP) Formulation Development in Drug Delivery is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Polymer Nanoparticles (PNP) Formulation Development include WuXi TIDES, Evonik, Sirnaomics, Cytiva, Ardena Holding NV, Ascension Sciences, Curapath, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Polymer Nanoparticles (PNP) Formulation Development, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Polymer Nanoparticles (PNP) Formulation Development.
The Polymer Nanoparticles (PNP) Formulation Development market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Polymer Nanoparticles (PNP) Formulation Development market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Polymer Nanoparticles (PNP) Formulation Development companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
WuXi TIDES
Evonik
Sirnaomics
Cytiva
Ardena Holding NV
Ascension Sciences
Curapath
Segment by Type
PLGA Nanoparticles Based
PGA Nanoparticles Based
PLA Nanoparticles Based
Other
Segment by Application
Drug Delivery
Vaccine Development
Other
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Polymer Nanoparticles (PNP) Formulation Development company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Polymer Nanoparticles (PNP) Formulation Development Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 PLGA Nanoparticles Based
1.2.3 PGA Nanoparticles Based
1.2.4 PLA Nanoparticles Based
1.2.5 Other
1.3 Market by Application
1.3.1 Global Polymer Nanoparticles (PNP) Formulation Development Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Drug Delivery
1.3.3 Vaccine Development
1.3.4 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Polymer Nanoparticles (PNP) Formulation Development Market Perspective (2019-2030)
2.2 Global Polymer Nanoparticles (PNP) Formulation Development Growth Trends by Region
2.2.1 Global Polymer Nanoparticles (PNP) Formulation Development Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Polymer Nanoparticles (PNP) Formulation Development Historic Market Size by Region (2019-2024)
2.2.3 Polymer Nanoparticles (PNP) Formulation Development Forecasted Market Size by Region (2025-2030)
2.3 Polymer Nanoparticles (PNP) Formulation Development Market Dynamics
2.3.1 Polymer Nanoparticles (PNP) Formulation Development Industry Trends
2.3.2 Polymer Nanoparticles (PNP) Formulation Development Market Drivers
2.3.3 Polymer Nanoparticles (PNP) Formulation Development Market Challenges
2.3.4 Polymer Nanoparticles (PNP) Formulation Development Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Polymer Nanoparticles (PNP) Formulation Development Players by Revenue
3.1.1 Global Top Polymer Nanoparticles (PNP) Formulation Development Players by Revenue (2019-2024)
3.1.2 Global Polymer Nanoparticles (PNP) Formulation Development Revenue Market Share by Players (2019-2024)
3.2 Global Polymer Nanoparticles (PNP) Formulation Development Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Polymer Nanoparticles (PNP) Formulation Development Revenue
3.4 Global Polymer Nanoparticles (PNP) Formulation Development Market Concentration Ratio
3.4.1 Global Polymer Nanoparticles (PNP) Formulation Development Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Polymer Nanoparticles (PNP) Formulation Development Revenue in 2023
3.5 Global Key Players of Polymer Nanoparticles (PNP) Formulation Development Head office and Area Served
3.6 Global Key Players of Polymer Nanoparticles (PNP) Formulation Development, Product and Application
3.7 Global Key Players of Polymer Nanoparticles (PNP) Formulation Development, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Polymer Nanoparticles (PNP) Formulation Development Breakdown Data by Type
4.1 Global Polymer Nanoparticles (PNP) Formulation Development Historic Market Size by Type (2019-2024)
4.2 Global Polymer Nanoparticles (PNP) Formulation Development Forecasted Market Size by Type (2025-2030)
5 Polymer Nanoparticles (PNP) Formulation Development Breakdown Data by Application
5.1 Global Polymer Nanoparticles (PNP) Formulation Development Historic Market Size by Application (2019-2024)
5.2 Global Polymer Nanoparticles (PNP) Formulation Development Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Polymer Nanoparticles (PNP) Formulation Development Market Size (2019-2030)
6.2 North America Polymer Nanoparticles (PNP) Formulation Development Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Polymer Nanoparticles (PNP) Formulation Development Market Size by Country (2019-2024)
6.4 North America Polymer Nanoparticles (PNP) Formulation Development Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Polymer Nanoparticles (PNP) Formulation Development Market Size (2019-2030)
7.2 Europe Polymer Nanoparticles (PNP) Formulation Development Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Polymer Nanoparticles (PNP) Formulation Development Market Size by Country (2019-2024)
7.4 Europe Polymer Nanoparticles (PNP) Formulation Development Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Polymer Nanoparticles (PNP) Formulation Development Market Size (2019-2030)
8.2 Asia-Pacific Polymer Nanoparticles (PNP) Formulation Development Market Growth Rate by Country: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Polymer Nanoparticles (PNP) Formulation Development Market Size by Region (2019-2024)
8.4 Asia-Pacific Polymer Nanoparticles (PNP) Formulation Development Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Polymer Nanoparticles (PNP) Formulation Development Market Size (2019-2030)
9.2 Latin America Polymer Nanoparticles (PNP) Formulation Development Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Polymer Nanoparticles (PNP) Formulation Development Market Size by Country (2019-2024)
9.4 Latin America Polymer Nanoparticles (PNP) Formulation Development Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Polymer Nanoparticles (PNP) Formulation Development Market Size (2019-2030)
10.2 Middle East & Africa Polymer Nanoparticles (PNP) Formulation Development Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Polymer Nanoparticles (PNP) Formulation Development Market Size by Country (2019-2024)
10.4 Middle East & Africa Polymer Nanoparticles (PNP) Formulation Development Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 WuXi TIDES
11.1.1 WuXi TIDES Company Details
11.1.2 WuXi TIDES Business Overview
11.1.3 WuXi TIDES Polymer Nanoparticles (PNP) Formulation Development Introduction
11.1.4 WuXi TIDES Revenue in Polymer Nanoparticles (PNP) Formulation Development Business (2019-2024)
11.1.5 WuXi TIDES Recent Development
11.2 Evonik
11.2.1 Evonik Company Details
11.2.2 Evonik Business Overview
11.2.3 Evonik Polymer Nanoparticles (PNP) Formulation Development Introduction
11.2.4 Evonik Revenue in Polymer Nanoparticles (PNP) Formulation Development Business (2019-2024)
11.2.5 Evonik Recent Development
11.3 Sirnaomics
11.3.1 Sirnaomics Company Details
11.3.2 Sirnaomics Business Overview
11.3.3 Sirnaomics Polymer Nanoparticles (PNP) Formulation Development Introduction
11.3.4 Sirnaomics Revenue in Polymer Nanoparticles (PNP) Formulation Development Business (2019-2024)
11.3.5 Sirnaomics Recent Development
11.4 Cytiva
11.4.1 Cytiva Company Details
11.4.2 Cytiva Business Overview
11.4.3 Cytiva Polymer Nanoparticles (PNP) Formulation Development Introduction
11.4.4 Cytiva Revenue in Polymer Nanoparticles (PNP) Formulation Development Business (2019-2024)
11.4.5 Cytiva Recent Development
11.5 Ardena Holding NV
11.5.1 Ardena Holding NV Company Details
11.5.2 Ardena Holding NV Business Overview
11.5.3 Ardena Holding NV Polymer Nanoparticles (PNP) Formulation Development Introduction
11.5.4 Ardena Holding NV Revenue in Polymer Nanoparticles (PNP) Formulation Development Business (2019-2024)
11.5.5 Ardena Holding NV Recent Development
11.6 Ascension Sciences
11.6.1 Ascension Sciences Company Details
11.6.2 Ascension Sciences Business Overview
11.6.3 Ascension Sciences Polymer Nanoparticles (PNP) Formulation Development Introduction
11.6.4 Ascension Sciences Revenue in Polymer Nanoparticles (PNP) Formulation Development Business (2019-2024)
11.6.5 Ascension Sciences Recent Development
11.7 Curapath
11.7.1 Curapath Company Details
11.7.2 Curapath Business Overview
11.7.3 Curapath Polymer Nanoparticles (PNP) Formulation Development Introduction
11.7.4 Curapath Revenue in Polymer Nanoparticles (PNP) Formulation Development Business (2019-2024)
11.7.5 Curapath Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer

Companies Mentioned:

WuXi TIDES
Evonik
Sirnaomics
Cytiva
Ardena Holding NV
Ascension Sciences
Curapath

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂